首页> 外文期刊>Journal of Clinical Pathology >Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry
【24h】

Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

机译:对人类乳腺癌中KCNJ3基因产物检测的关键评估:mRNA原位杂交优于免疫组化

获取原文
获取原文并翻译 | 示例
       

摘要

Increased expression levels of KCNJ3 have been correlated with lymph node metastases and poor prognosis in patients with breast cancer, suggesting a prognostic role of KCNJ3. We aimed to establish protocols for the detection of KCNJ3 in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissue. Several antibodies were tested for sensitivity and specificity by western blot, followed by optimisation of the immunohistochemistry (IHC) procedure and establishment of KCNJ3 mRNA in situ hybridisation (ISH). Methods were validated by processing 15 FFPE breast cancer samples for which microarray data were available. Spearman's rank correlation analysis resulted in borderline significant correlation for IHC versus ISH (rS: 0.625; p< 0.05) and IHC versus microarray (rS: 0.668; p< 0.01), but in significant correlation for ISH versus microarray (rS: 0.861; p< 0.001). The ISH method was superior to IHC, regarding robustness, sensitivity and specificity and will aid to further study expression levels of KCNJ3 in both malignant and physiological conditions.
机译:KCNJ3的表达水平升高与乳腺癌患者的淋巴结转移和不良预后相关,提示KCNJ3的预后作用。我们旨在建立在福尔马林固定,石蜡包埋(FFPE)乳腺癌组织中检测KCNJ3的方案。通过Western印迹测试了几种抗体的敏感性和特异性,然后优化了免疫组织化学(IHC)程序并建立了KCNJ3 mRNA原位杂交(ISH)。通过处理可获得的微阵列数据的15个FFPE乳腺癌样品来验证方法。 Spearman的秩相关分析得出IHC与ISH(rS:0.625; p <0.05)和IHC与微阵列(rS:0.668; p <0.01)的临界显着相关性,但ISH与微阵列之间的显着相关性(rS:0.861; p <0.001)。 ISH方法在鲁棒性,敏感性和特异性方面优于IHC,将有助于进一步研究KCNJ3在恶性和生理条件下的表达水平。

著录项

  • 来源
    《Journal of Clinical Pathology》 |2016年第12期|1116-1121|共6页
  • 作者单位

    Med Univ Graz, Inst Biophys, Mol Physiol Grp, Graz, Austria|Med Univ Graz, Res Unit Ion Channels & Canc Biol, Graz, Austria;

    Med Univ Graz, Inst Pathol, Graz, Austria;

    Med Univ Graz, Inst Pathol, Graz, Austria;

    Med Univ Graz, Inst Pathol, Graz, Austria;

    Med Univ Graz, Inst Biophys, Mol Physiol Grp, Graz, Austria|Med Univ Graz, Res Unit Ion Channels & Canc Biol, Graz, Austria;

    Med Univ Graz, Inst Pathol, Graz, Austria;

    Med Univ Graz, Div Oncol, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria;

    Med Univ Graz, Inst Biophys, Mol Physiol Grp, Graz, Austria|Med Univ Graz, Res Unit Ion Channels & Canc Biol, Graz, Austria;

    Med Univ Graz, Res Unit Ion Channels & Canc Biol, Graz, Austria|Med Univ Graz, Div Oncol, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:32:14

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号